In focus
Latest feed
The Future of US Pharma: Dr. Reddy's CEO Predicts Biosimilars to Eclipse Generics by Early 2030s
The Pharmaceutical Frontier: Biosimilars on the Rise
The Next Big Leap: Indian Pharma's Race for the Semaglutide Jackpot
A Game Changer for Health: Generic Semaglutide Slashes Prices in India, Offering New Hope
